Developed by AVA co-founder, Andrew Eisen, MD, PhD, DRAP is the recombinant form of a unique protein found in Drosophila embryos.  DRAP posesses  two discrete properties – homology-dependent DNA strand exchange and a resolving, topoisomerase-like activity.  AVA has developed techniques to exploit these properties for the introduction of DNA into living systems.






DRAP Technology
Applications of this technology are broad, and include

  • Creation of Genetic Animal Models
  • Advancing Biomedical Research
  • Biopharmaceutical Manufacturing
  • Clinical Applications in Gene Therapy
Applications